Study of CD38 and CD56 in Chronic Myeloid Leukemia (NCT07740603) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Study of CD38 and CD56 in Chronic Myeloid Leukemia
200 participantsStarted 2026-09-01
Plain-language summary
Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow.
The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* patients with chronic myeloid leukemia
Exclusion Criteria:
* other hematological diseases
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is measuring changes in CD38 and CD56 markers in CML patients — can you explain what those markers tell us about my disease, and whether knowing my levels of them could actually affect my treatment plan?
2Since this trial isn't recruiting yet, how long might it realistically be before it opens, and is there any reason to wait for it rather than starting standard treatment like a tyrosine kinase inhibitor now?
3This study is listed as Phase 'NA,' which suggests it may be observational or diagnostic rather than testing a treatment — can you help me understand whether joining this study would change anything about the care I receive, or would it just involve extra blood tests or measurements?
4Given that this trial is focused on studying CD38 and CD56 as markers rather than trialing a new therapy, would the findings from this kind of research be relevant to my specific case, and are there other studies testing actual CML treatments that might be worth considering alongside this one?
5If I were eventually eligible to participate in this study, what would be involved practically — how many visits, what kinds of tests, and would any of that interfere with my ongoing CML treatment?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
an increased change in cd 38 and cd 56 in chronic leukemic patients